AFG
HZNP

American Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

American Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,876
Closed -$229K – 155
2016
Q2 		$229K Buy
+13,876
New +$224K 0.02% 139

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Financial Group's HZNP Position: Q3 2016 in Review

American Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2016, closing a stake of 13,876 shares — an estimated $229K sold.

American Financial Group first reported a position in HZNP in Q2 2016 and held it in 1 quarter. The position peaked at $229K in Q2 2016. 232 funds tracked by Wall St. Rank hold HZNP as of Q3 2016.

  • American Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2016 after selling out during the quarter.
  • American Financial Group sold 13,876 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2016, an estimated $229K.
  • American Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 1 quarter.
  • American Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $229K in Q2 2016.
  • 232 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2016.

Based on American Financial Group's 13F filing for Q3 2016, filed 4 Nov 2016.